trustme.bro/r/…
✓ checked
trust me, bro:
here is the receipt.
the claim
Pentasa is an immunosuppressive drug.
the verdict
REFUTED
the evidence says no
confidence 22/100

Pentasa contains mesalazine (5-aminosalicylic acid), which acts locally as an anti-inflammatory agent in the gastrointestinal tract rather than as an immunosuppressive drug.

Evidence against · 2
Mesalazine in inflammatory bowel disease: a trendy topic once again?
2010 · cited by 127
Paper [0] identifies Pentasa's active ingredient as mesalazine (5-ASA), a conventional anti-inflammatory and chemopreventive agent distinct from true immunosuppressants.
See more details
More against · 1
The 2023 Impact of Inflammatory Bowel Disease in Canada: Treatment Landscape.
2023 · cited by 10
Paper [3] contrasts traditional anti-metabolite immunomodulators and targeted biologics with conventional treatments like 5-ASAs for inflammatory bowel disease.
The paper trail · every fact has a biography
first checked02 Aug 2026
judged → REFUTED · 2202 Aug 2026
This receipt carries no identity, shared or not. Sharing publishes your connection to it, not your data.
Check your own claim
Challenge the receipt
trust me, bro: win the argument, pass the class, survive peer review.
This receipt is an automated verdict against our published method · not an opinion about any author or publication.
Terms · Privacy · How verdicts work · Dispute this receipt